Bactana Corp.

We develop products to (1) help livestock farmers increase meat production without antibiotics, and (2) help companion animals with digestive and joint ailments

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Farmington, CT, USA
  • Currency USD
  • Founded January 2017
  • Employees 4
  • Incorporation Type C-corp
  • Website bactana.com

Company Summary

Bactana leverages the interaction of an animal’s microbiome with its immune system and metabolism (immunometabolism) to develop safe and effective treatments for pets and to help livestock farmers.

LIVESTOCK: Farmers are under great pressure to eliminate antibiotics & hormones from food animals.

PETS: Digestive ailments and joint problems are among the most common problems for pets and owners have limited choices to treat them.

Team

  • John Kallassy
    CEO & Co-founder

    Helped launch and exit/IPO three businesses
    Former CEO of Zargis Medical, which sold to 3M in 2010
    Awarded “2009 Product of the Year” by Popular Science Magazine
    Co-founded FINRA licensed broker dealer I-Bankers Direct to advise emerging technology and life science companies
    Studied pharmacology and biology as an undergraduate

  • Rodrigo Bicalho
    CSO & Co-founder

    Professor at Cornell’s College of Veterinary Medicine.

    One of the worlds leading expert & lecturers on dairy cattle microbiome and health

    Published over 100 scientific articles

    Beginning in 2012, Dr. Bicalho and his team at Cornell University made the scientific discoveries that are the foundation of Bactana’s flagship product

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free